# Create Medicines **Source:** https://www.startuphub.ai/startups/create-medicines **Profile type:** Startup > Developing in vivo immunotherapies for autoimmune diseases and cancer. ## About Create Medicines is a biotechnology startup focused on developing in vivo immunotherapies. Their approach targets autoimmune diseases and cancer by leveraging the body's own immune system. The company has secured significant Series B funding to advance its research and development efforts. ## Key facts - **Slug:** create-medicines - **Location:** Cambridge, Massachusetts, USA - **Operating status:** Active - **Total funding:** $122M - **Sectors / tags:** Biotechnology, HealthTech, Pharmaceuticals ## Frequently asked ### What does Create Medicines do? Create Medicines is a biotechnology startup focused on developing in vivo immunotherapies. Their approach targets autoimmune diseases and cancer by leveraging the body's own immune system. The company has secured significant Series B funding to advance its research and development efforts. ### What is Create Medicines's revenue? StartupHub estimates Create Medicines's annual revenue at $13.1M (range $4.4M to $61.0M, 34% confidence), based on comparable companies in the sector. ### What is Create Medicines's valuation? StartupHub estimates Create Medicines's effective valuation at $512.4M (range $305.0M to $732.0M, 24% confidence), based on comparable companies in the sector. ### How much funding has Create Medicines raised? Create Medicines has raised a total of $122M in funding. The most recent round on record is Series B. ### Where is Create Medicines headquartered? Create Medicines is headquartered in Cambridge, Massachusetts, USA. ### What industry does Create Medicines operate in? Create Medicines operates in Biotechnology, HealthTech, Pharmaceuticals. ## JSON-LD Structured data aligned with this page's `